Background and aims: Statin associated muscle symptoms are common and affect adherence to statin treatment. The objective of this study was to assess whether patients with statin-associated myalgia can be successfully treated with Coenzyme Q10 (CoQ10) to improve symptoms and maintain them on statin therapy.
Methods: This systematic review was performed in line with the 2015 PRISMA statement. Relevant studies were identified via a search of MEDLINE, EMBASE and the Cochrane Library. Studies were screened to include randomised controlled trials of oral CoQ10 supplementation versus a placebo in adults with statin-associated myalgia. Continuation of statin therapy was a secondary outcome. Risk of bias was assessed using the Cochrane Risk of Bias tool. Pooled and sensitivity analyses were performed.
Results: 413 records were identified by the search strategy. Eight studies were selected for review, and 7 of them (with 321 patients) were included in the meta-analysis. Selected studies were published between 2007 and 2016 with the number of participants ranging from 37 to 76. Only two of these studies demonstrated a positive effect of CoQ10 therapy in relieving muscle pain. The meta-analysis did not demonstrate any benefit of CoQ10 supplementation in improving myalgia symptoms compared to placebo (weighted mean difference -0.42; 95% Confidence Interval [CI] -1.47 to 0.62). Similarly, CoQ10 did not improve the proportion of patients remaining on the statin treatment (RR 0.99; 95%CI, 0.81 to 1.20).
Conclusions: This systematic review and meta-analysis did not demonstrate that CoQ10 supplementation was beneficial for patients with statin-associated muscle pain or improved adherence to statin therapy.
Keywords: Adherence; CoQ10; Coenzyme Q10; Hypercholesterolemia; Myalgia; Myopathy; Statin; Ubiquinone.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.
Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.J Am Heart Assoc. 2018 Oct 2;7(19):e009835. doi: 10.1161/JAHA.118.009835. J Am Heart Assoc. 2018. PMID: 30371340 Free PMC article. Review.
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.Mayo Clin Proc. 2015 Jan;90(1):24-34. doi: 10.1016/j.mayocp.2014.08.021. Epub 2014 Nov 14. Mayo Clin Proc. 2015. PMID: 25440725
A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.Atherosclerosis. 2015 Feb;238(2):329-35. doi: 10.1016/j.atherosclerosis.2014.12.016. Epub 2014 Dec 17. Atherosclerosis. 2015. PMID: 25545331 Free PMC article. Clinical Trial.
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2014;(12):CD010405. doi: 10.1002/14651858.CD010405.pub2. Epub 2014 Dec 4. Cochrane Database Syst Rev. 2014. PMID: 25474484 Review.
The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials.Eur J Med Res. 2018 Nov 10;23(1):57. doi: 10.1186/s40001-018-0353-6. Eur J Med Res. 2018. PMID: 30414615 Free PMC article. Review.